• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW MEDICAL LTD. IV3000 1 HAND 10X12CM CTN 50; TAPE AND BANDAGE, ADHESIVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW MEDICAL LTD. IV3000 1 HAND 10X12CM CTN 50; TAPE AND BANDAGE, ADHESIVE Back to Search Results
Model Number 66024008
Device Problem Biocompatibility (2886)
Patient Problems Blister (4537); Skin Inflammation/ Irritation (4545)
Event Date 08/28/2022
Event Type  Injury  
Manufacturer Narrative
Internal complaint reference: (b)(4).
 
Event Description
It was reported that, a right thoracic drainage tube was placed on the patient, two days later the skin at the edge of one (1) iv3000 1 hand 10x12cm ctn 50 was found red.The dressing was replaced, and four days later, blisters were scattered around.The next day, the blisters had ruptured, that same day, patient underwent chest ct examination and the pleural effusion was reduced.The thoracic drainage and the film were removed according to the doctor's advice.Lyophilized recombinant human acidic fibroblast growth factor for external use was applied.Current patient's health status is unknown.
 
Manufacturer Narrative
Section h3, h6: it was reported that, a right thoracic drainage tube was placed on the patient, two days later the skin at the edge of one (1) iv3000 1 hand 10x12cm ctn 50 was found red.The dressing was replaced, and four days later, blisters were scattered around.The next day, the blisters had ruptured, that same day, patient underwent chest ct examination and the pleural effusion was reduced.The thoracic drainage and the film were removed according to the doctor's advice.Lyophilized recombinant human acidic fibroblast growth factor for external use was applied.Current patient's health status is unknown.The device was not returned for analysis.We have therefore not been able to confirm a relationship between the event and the device, or identify a definitive root cause.A lot number for the device was not provided, therefore it was not possible to carry out a device history review.A complaint history review (chr) revealed a small number of similar instances in the last 12 months.There is nothing to indicate this is outside of acceptable rates of occurrence.A clinical/medical evaluation was conducted, and was unable to rule out a procedural variance as a contributing factor to the reported event, rather than the device itself not functioning correctly.The iv3000 standard should be used on iv sites only.If a film dressing is required for open wounds such as pressure sores, burns, or donor sites, opsite flexigrid should be used.The health status of the patient is unknown, therefore the impact to the patient beyond that which has already reported cannot be confirmed nor concluded.Consequently, no further clinical/medical assessment is warranted at this time.A risk management review was conducted and which mitigated the reported issue with no further action or updates required.The ifu has been reviewed and contains comprehensive instructions on the safe operation and use of the device, including specific direction that the product should only be used on iv sites and precautionary advice where sensitive/fragile skin is an issue.A review of records held concluded that there are no prior escalated actions related to this product and the reported event.The probable root cause for this complaint is that the patient's skin was sensitive to one or more of the components of the dressing, leading to the reaction as reported in the complaint detail.Existing skin condition(s) might also be a contributing factor, as could the choice of dressing for the intended purpose.The users of the reported product are advised to consult the relevant ifu, to prevent future occurrences of the reported issue.Investigations into this matter are now complete.No further actions by smith & nephew are deemed necessary at this stage.However, we will continue to monitor for any adverse trends relating to this product range.Smith & nephew acknowledge customer concern and are continually investigating ways to develop and improve our products.H6: health effect - impact code.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IV3000 1 HAND 10X12CM CTN 50
Type of Device
TAPE AND BANDAGE, ADHESIVE
Manufacturer (Section D)
SMITH & NEPHEW MEDICAL LTD.
101 hessle road
hull east riding of yorkshire HU3 2 BN
UK  HU3 2BN
Manufacturer (Section G)
SMITH & NEPHEW MEDICAL LTD.
101 hessle road
hull east riding of yorkshire HU3 2 BN
UK   HU3 2BN
Manufacturer Contact
holly topping
7000 west william cannon drive
austin, TX 78735
5123913905
MDR Report Key16134889
MDR Text Key307062228
Report Number8043484-2023-00007
Device Sequence Number1
Product Code KGX
UDI-Device Identifier05000223417406
UDI-Public05000223417406
Combination Product (y/n)N
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 03/21/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number66024008
Device Catalogue Number4008
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 12/16/2022
Initial Date FDA Received01/10/2023
Supplement Dates Manufacturer Received03/17/2023
Supplement Dates FDA Received03/21/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-